ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Bharat Parenterals Limited shares have been admitted to trade on the National Stock Exchange under the 'Permitted to Trade' category effective August 17, 2026.
Bharat Parenterals submitted its FY2026 Annual Secretarial Compliance Report. The independent auditor confirmed compliance with SEBI regulations, noting only a minor past administrative fine.
Bharat Parenterals Limited submitted its compliance certificate under Regulation 74(5) for the quarter ended March 31, 2026. The Registrar and Share Transfer Agent, Adroit Corporate Services, confirmed that securities received for dematerialisation were processed and listed on stock exchanges within the mandated 15-day period.